The EZH1 Y642F mutation was detected in all tumor samples with variant allele frequency (VAF) 36.1%, 37.9%, and 18.9% in Out‐N, In‐N, and skin tumor, respectively. This evidence concerns the gene EZH1 and neoplasm.